Stryker Corporation (SYK) - Total Assets
Based on the latest financial reports, Stryker Corporation (SYK) holds total assets worth $47.84 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore SYK debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Stryker Corporation - Total Assets Trend (1985–2025)
This chart illustrates how Stryker Corporation's total assets have evolved over time, based on quarterly financial data. See Stryker Corporation (SYK) net assets for net asset value and shareholders' equity analysis.
Stryker Corporation - Asset Composition Analysis
Current Asset Composition (December 2025)
Stryker Corporation's total assets of $47.84 Billion consist of 30.8% current assets and 69.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $4.01 Billion | 8.4% |
| Accounts Receivable | $4.04 Billion | 8.4% |
| Inventory | $5.31 Billion | 11.1% |
| Property, Plant & Equipment | $3.88 Billion | 8.1% |
| Intangible Assets | $24.97 Billion | 52.2% |
| Goodwill | $24.97 Billion | 52.2% |
Asset Composition Trend (1985–2025)
This chart illustrates how Stryker Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Stryker Corporation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Stryker Corporation's current assets represent 30.8% of total assets in 2025, a decrease from 76.5% in 1985.
- Cash Position: Cash and equivalents constituted 8.4% of total assets in 2025, down from 17.1% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 104.0% of total assets, an increase from 1.0% in 1985.
- Asset Diversification: The largest asset category is goodwill at 52.2% of total assets.
Stryker Corporation Competitors by Total Assets
Key competitors of Stryker Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Edwards Lifesciences Corp
NYSE:EW
|
USA | $13.32 Billion |
|
DexCom Inc
NASDAQ:DXCM
|
USA | $6.63 Billion |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
|
China | CN¥1.86 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Corentec Co Ltd
KQ:104540
|
Korea | ₩175.16 Billion |
|
Adherium Ltd
AU:ADR
|
Australia | AU$4.16 Million |
Stryker Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.89 | 1.95 | 2.27 |
| Quick Ratio | 1.21 | 1.32 | 1.39 |
| Cash Ratio | 0.51 | 0.48 | 0.00 |
| Working Capital | $6.96 Billion | $7.23 Billion | $5.03 Billion |
Stryker Corporation - Advanced Valuation Insights
This section examines the relationship between Stryker Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.25 |
| Latest Market Cap to Assets Ratio | 2.61 |
| Asset Growth Rate (YoY) | 11.3% |
| Total Assets | $47.84 Billion |
| Market Capitalization | $124.64 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Stryker Corporation's assets at a significant premium (2.61x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Stryker Corporation's assets grew by 11.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Stryker Corporation (1985–2025)
The table below shows the annual total assets of Stryker Corporation from 1985 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $47.84 Billion | +11.34% |
| 2024-12-31 | $42.97 Billion | +7.66% |
| 2023-12-31 | $39.91 Billion | +8.21% |
| 2022-12-31 | $36.88 Billion | +6.51% |
| 2021-12-31 | $34.63 Billion | +0.88% |
| 2020-12-31 | $34.33 Billion | +13.80% |
| 2019-12-31 | $30.17 Billion | +10.79% |
| 2018-12-31 | $27.23 Billion | +22.75% |
| 2017-12-31 | $22.18 Billion | +8.55% |
| 2016-12-31 | $20.43 Billion | +25.78% |
| 2015-12-31 | $16.25 Billion | -8.28% |
| 2014-12-31 | $17.71 Billion | +12.51% |
| 2013-12-31 | $15.74 Billion | +16.90% |
| 2012-12-31 | $13.47 Billion | +8.56% |
| 2011-12-31 | $12.40 Billion | +13.86% |
| 2010-12-31 | $10.90 Billion | +20.11% |
| 2009-12-31 | $9.07 Billion | +19.31% |
| 2008-12-31 | $7.60 Billion | +3.39% |
| 2007-12-31 | $7.35 Billion | +25.20% |
| 2006-12-31 | $5.87 Billion | +18.80% |
| 2005-12-31 | $4.94 Billion | +21.07% |
| 2004-12-31 | $4.08 Billion | +29.27% |
| 2003-12-31 | $3.16 Billion | +12.20% |
| 2002-12-31 | $2.82 Billion | +16.17% |
| 2001-12-31 | $2.42 Billion | -0.30% |
| 2000-12-31 | $2.43 Billion | -5.80% |
| 1999-12-31 | $2.58 Billion | -10.58% |
| 1998-12-31 | $2.89 Billion | +192.96% |
| 1997-12-31 | $985.10 Million | -0.85% |
| 1996-12-31 | $993.50 Million | +16.21% |
| 1995-12-31 | $854.90 Million | +11.32% |
| 1994-12-31 | $768.00 Million | +69.09% |
| 1993-12-31 | $454.20 Million | +33.47% |
| 1992-12-31 | $340.30 Million | +25.90% |
| 1991-12-31 | $270.30 Million | +29.02% |
| 1990-12-31 | $209.50 Million | +37.56% |
| 1989-12-31 | $152.30 Million | +22.04% |
| 1988-12-31 | $124.80 Million | +18.86% |
| 1987-12-31 | $105.00 Million | +22.09% |
| 1986-12-31 | $86.00 Million | +21.64% |
| 1985-12-31 | $70.70 Million | -- |
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment … Read more